BEUDAMED
    FDA Adverse Event Injury Summary report: N

    ENDURANT STENT GRAFT

    MDR report key: 21890635 · Received April 23, 2025

    Report

    Report Number
    9612164-2025-02023
    Event Type
    Injury
    Date Received
    April 23, 2025
    Date of Event
    January 27, 2025
    Report Date
    April 23, 2025
    Manufacturer
    MEDTRONIC IRELAND
    Product Code
    MIH
    PMA / PMN Number
    P100021
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    MEDTRONIC RECEIVED THE FOLLOWING INFORMATION FROM A JOURNAL ARTICLE ENTITLED; ¿COMPARISON OF TREATMENT OUTCOMES BETWEEN GRAFT REPLACEMENT AND ANEURYSMORRHAPHY WITH GRAFT PRESERVATION FOR TYPE 2 ENDOLEAKS AFTER ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR¿. MORISAKI K, YOSHINO S, MATSUDA D, KUROSE S, OKADOME J, NAKAYAMA K, YOSHIGA R, INOUE K, FURUYAMA T, YAMAOKA T, KUME M, MATSUMOTO T, OKAZAKI J, ITO H, ONOHARA T, YOSHIZUMI T ANNALS OF VASCULAR SURGERY. 2025 APR; 113:186-194. DOI: 10.1016/J.AVSG.2025.01.015. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

    Description of Event or Problem · 0

    LITERATURE WAS REVIEWED REGARDING ¿COMPARISON OF TREATMENT OUTCOMES BETWEEN GRAFT REPLACEMENT AND ANEURYSMORRHAPHY WITH GRAFT PRESERVATION FOR TYPE 2 ENDOLEAKS AFTER ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR¿. THE TIME FRAME OF THIS STUDY WAS OVER A FIFTEEN YEAR PERIOD. ENDURANT AND NON-MDT STENT GRAFTS WERE IMPLANTED IN THE PATIENT POPULATION. THE FOLLOWING ADVERSE EVENTS OCCURRED: INFECTION, INTERVENTION NO FURTHER INFORMATION WAS PROVIDED PERTAINING TO MEDTRONIC PRODUCTS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1291612 ENDURANT STENT GRAFT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR MIH MEDTRONIC IRELAND UNK-CV-SR-ENDURANT

    Patients

    Seq Age Sex Outcome Treatment
    1 78 YR Male Required Intervention